Immunologic Diseases Beijing

Mar 15, 2023 | onlinelibrary.wiley.com | Xinping Tian |Immunologic Diseases Beijing |Mengtao Li

Study protocol This is a single-center, open label, prospective, cohort study. Active disease was assessed by the National Institutes of Health criteria for active TAK (29) or the EULAR criteria (17), with patients considered to have active disease if they met either of the 2 definitions.